These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 9096248)

  • 1. Role of noradrenergic functions in the modification of naloxone-precipitated withdrawal jumping in morphine-dependent mice by diabetes.
    Kamei J; Ohsawa M
    Life Sci; 1997; 60(15):PL223-8. PubMed ID: 9096248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modification of the expression of naloxone-precipitated withdrawal signs in morphine-dependent mice by diabetes: possible involvement of protein kinase C.
    Ohsawa M; Kamei J
    Jpn J Pharmacol; 1999 Mar; 79(3):303-11. PubMed ID: 10230858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of intracellular calcium on the modulation of naloxone-precipitated withdrawal jumping in morphine-dependent mice by diabetes.
    Ohsawa M; Kamei J
    Brain Res; 1999 Jan; 815(2):424-30. PubMed ID: 9878862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diazepam pretreatment suppresses morphine withdrawal signs in the mouse.
    Suzuki T; Tsuda M; Narita M; Funada M; Mizoguchi H; Misawa M
    Life Sci; 1996; 58(4):349-57. PubMed ID: 8538371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naloxone-precipitated withdrawal enhances ERK phosphorylation in prefrontal association cortex and accumbens nucleus of morphine-dependent mice.
    Li T; Hou Y; Cao W; Yan CX; Chen T; Li SB
    Neurosci Lett; 2010 Jan; 468(3):348-52. PubMed ID: 19922770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of corticotropin-releasing factor receptor subtype 1 in morphine withdrawal regulation of the brain noradrenergic system.
    Funada M; Hara C; Wada K
    Eur J Pharmacol; 2001 Nov; 430(2-3):277-81. PubMed ID: 11711043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenylmethanesulfonyl fluoride, a serine protease inhibitor, suppresses naloxone-precipitated withdrawal jumping in morphine-dependent mice.
    Nemoto W; Sato T; Nakagawasai O; Yaoita F; Silberring J; Tadano T; Tan-No K
    Neuropeptides; 2013 Jun; 47(3):187-91. PubMed ID: 23290539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naloxone-precipitated withdrawal jumping in 11 inbred mouse strains: evidence for common genetic mechanisms in acute and chronic morphine physical dependence.
    Kest B; Palmese CA; Hopkins E; Adler M; Juni A; Mogil JS
    Neuroscience; 2002; 115(2):463-9. PubMed ID: 12421612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of naloxone-precipitated withdrawal jumps in morphine-dependent mice by stimulation of prostaglandin EP3 receptor.
    Nakagawa T; Minami M; Katsumata S; Ienaga Y; Satoh M
    Br J Pharmacol; 1995 Nov; 116(6):2661-6. PubMed ID: 8590986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous cannabinoid, 2-arachidonoylglycerol, attenuates naloxone-precipitated withdrawal signs in morphine-dependent mice.
    Yamaguchi T; Hagiwara Y; Tanaka H; Sugiura T; Waku K; Shoyama Y; Watanabe S; Yamamoto T
    Brain Res; 2001 Aug; 909(1-2):121-6. PubMed ID: 11478928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of noradrenergic system within the central nucleus of the amygdala in naloxone-precipitated morphine withdrawal-induced conditioned place aversion in rats.
    Watanabe T; Nakagawa T; Yamamoto R; Maeda A; Minami M; Satoh M
    Psychopharmacology (Berl); 2003 Oct; 170(1):80-8. PubMed ID: 12768272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naloxone rapidly evokes endogenous kappa opioid receptor-mediated hyperalgesia in naïve mice pretreated briefly with GM1 ganglioside or in chronic morphine-dependent mice.
    Crain SM; Shen KF
    Brain Res; 2007 Sep; 1167():31-41. PubMed ID: 17692296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modification of mu-opioid agonist-induced locomotor activity and development of morphine dependence by diabetes.
    Kamei J; Ohsawa M; Saitoh A; Iwamoto Y; Suzuki T; Misawa M; Nagase H; Kasuya Y
    J Pharmacol Exp Ther; 1995 Aug; 274(2):700-6. PubMed ID: 7636731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo and in vitro attenuation of naloxone-precipitated experimental opioid withdrawal syndrome by insulin and selective KATP channel modulator.
    Singh P; Sharma B; Gupta S; Sharma BM
    Psychopharmacology (Berl); 2015 Jan; 232(2):465-75. PubMed ID: 25059539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of histaminergic-noradrenergic axis in naloxone-induced withdrawal symptoms in mice.
    el Kadi AO; Sharif SI
    Pharmacol Biochem Behav; 1996 Sep; 55(1):49-54. PubMed ID: 8870037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopaminergic influence on withdrawal jumping behavior in morphine-dependent mice.
    Tseng LF; Brase DA; Loh HH
    Res Commun Chem Pathol Pharmacol; 1976 Nov; 15(3):435-46. PubMed ID: 1033590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microarray analysis of genes expressed in the frontal cortex of rats chronically treated with morphine and after naloxone precipitated withdrawal.
    Ammon S; Mayer P; Riechert U; Tischmeyer H; Höllt V
    Brain Res Mol Brain Res; 2003 Apr; 112(1-2):113-25. PubMed ID: 12670709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphine tolerance and dependence in the nociceptin receptor knockout mice.
    Mamiya T; Noda Y; Ren X; Nagai T; Takeshima H; Ukai M; Nabeshima T
    J Neural Transm (Vienna); 2001; 108(12):1349-61. PubMed ID: 11810400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of 5-HT2 receptors in the expression of withdrawal diarrhea in morphine-dependent mice.
    Mori T; Komiya S; Ohya J; Uzawa N; Sugiyama K; Saitoh Y; Shibasaki M; Suzuki T
    Eur J Pharmacol; 2014 Oct; 740():160-7. PubMed ID: 25034809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acutely administered clozapine does not modify naloxone-induced withdrawal jumping in morphine-dependent mice.
    Ballard TM; McAllister KH
    Pharmacol Biochem Behav; 1999 Feb; 62(2):285-90. PubMed ID: 9972695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.